Mismatch repair deficiency in phenotypically normal human cells
- PMID: 7632227
- DOI: 10.1126/science.7632227
Mismatch repair deficiency in phenotypically normal human cells
Abstract
Tumor cells in patients with hereditary nonpolyposis colorectal cancer (HNPCC) are characterized by a genetic hypermutability caused by defects in DNA mismatch repair. A subset of HNPCC patients was found to have widespread mutations not only in their tumors, but also in their non-neoplastic cells. Although these patients had numerous mutations in all tissues examined, they had very few tumors. The hypermutability was associated with a profound defect in mismatch repair at the biochemical level. These results have implications for the relation between mutagenesis and carcinogenesis, and they suggest that mismatch repair deficiency is compatible with normal human development.
Comment in
-
Mutations not sufficient for carcinogenesis?Science. 1995 Aug 18;269(5226):909. doi: 10.1126/science.7638608. Science. 1995. PMID: 7638608 No abstract available.
-
Genetic chimerism.Science. 1995 Jun 16;268(5217):1552. doi: 10.1126/science.7777846. Science. 1995. PMID: 7777846 No abstract available.
Similar articles
-
Identification of DNA mismatch repair gene mutations in hereditary nonpolyposis colon cancer patients.Int J Cancer. 1996 Feb 20;69(1):50-2. doi: 10.1002/(SICI)1097-0215(19960220)69:1<50::AID-IJC12>3.0.CO;2-O. Int J Cancer. 1996. PMID: 8600061 Review.
-
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.Cancer Res. 1994 Sep 1;54(17):4590-4. Cancer Res. 1994. PMID: 8062247
-
Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.Biochim Biophys Acta. 1999 May 31;1423(3):O1-O10. doi: 10.1016/s0304-419x(99)00008-6. Biochim Biophys Acta. 1999. PMID: 10382540 Review.
-
Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.Cancer Res. 2002 Jan 1;62(1):38-42. Cancer Res. 2002. PMID: 11782355
-
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.Cancer Res. 1994 Apr 1;54(7):1645-8. Cancer Res. 1994. PMID: 8137274
Cited by
-
DNA mismatch repair in cancer immunotherapy.NAR Cancer. 2023 Jun 13;5(3):zcad031. doi: 10.1093/narcan/zcad031. eCollection 2023 Sep. NAR Cancer. 2023. PMID: 37325548 Free PMC article.
-
Mutational landscape of normal epithelial cells in Lynch Syndrome patients.Nat Commun. 2022 May 17;13(1):2710. doi: 10.1038/s41467-022-29920-2. Nat Commun. 2022. PMID: 35581206 Free PMC article.
-
Histology-agnostic drug development - considering issues beyond the tissue.Nat Rev Clin Oncol. 2020 Sep;17(9):555-568. doi: 10.1038/s41571-020-0384-0. Epub 2020 Jun 11. Nat Rev Clin Oncol. 2020. PMID: 32528101 Review.
-
A good start of immunotherapy in esophageal cancer.Cancer Med. 2019 Aug;8(10):4519-4526. doi: 10.1002/cam4.2336. Epub 2019 Jun 23. Cancer Med. 2019. PMID: 31231980 Free PMC article. Review.
-
Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer.Front Oncol. 2018 Dec 12;8:621. doi: 10.3389/fonc.2018.00621. eCollection 2018. Front Oncol. 2018. PMID: 30631754 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
